Blog Posts in March, 2005

  • More Cox-2 Chaos

    In February, an FDA advisory committee met to discuss the safety of the class of drugs known as Cox-2 inhibitors. Of course, this is the class getting a lot of press lately that includes Vioxx and Celebrex. Pfizer and Merck pharmaceutical companies where there, defending their drugs and making their plea to keep their money-makers on the market. At the conclusion of the three day seminar, the 32 ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.